2017 Spring Pharmaceutical EHS Counsel Roundtable

Below you will find the materials for the 2017 Spring Pharmaceutical EHS Counsel Roundtable, held on Wednesday, March 1 in Washington, DC.

• Agenda

• Presentations:
  • EPA RCRA Rulemakings Impacting the Management of Pharmaceutical Wastes
  • Global PIE Update
  • Congressional, Executive and Judicial Activities in the Trump Era
  • New Developments in Federal Regulation of Biotechnology Products
  • OSHA Compliance, Enforcement and Rulemakings
• Other Resources:

  • Beveridge & Diamond Firm Overview

  • Beveridge & Diamond's Pharmaceuticals, Health Care Practice

About the Roundtable

Launched in 2007, the Pharmaceutical EHS Counsel Roundtable provides an opportunity for in-house EHS counsel at leading pharmaceutical companies to meet and discuss emerging EHS legal issues pertaining to pharmaceutical products and operations in the U.S. and in key markets worldwide. The Roundtable also affords participants an opportunity to discuss compliance approaches, opportunities to reduce legal risks, and EHS aspects of supply chain management.